Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients

Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. Methods We evaluated whether some specific post-mortem features are observed in these patients and if these cha...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) Vol. 24; no. 1; pp. 495 - 10
Main Authors: Remmelink, Myriam, De Mendonça, Ricardo, D’Haene, Nicky, De Clercq, Sarah, Verocq, Camille, Lebrun, Laetitia, Lavis, Philomène, Racu, Marie-Lucie, Trépant, Anne-Laure, Maris, Calliope, Rorive, Sandrine, Goffard, Jean-Christophe, De Witte, Olivier, Peluso, Lorenzo, Vincent, Jean-Louis, Decaestecker, Christine, Taccone, Fabio Silvio, Salmon, Isabelle
Format: Journal Article
Language:English
Published: London BioMed Central 12.08.2020
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. Methods We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Results Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). Conclusions In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
AbstractList Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. Methods We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Results Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). Conclusions In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs. Keywords: COVID-19, SARS-CoV-2, Autopsy, RT-PCR, Immunohistochemistry
Abstract Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. Methods We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Results Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). Conclusions In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. Methods We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Results Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). Conclusions In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients.BACKGROUNDPost-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients.We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs.METHODSWe evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs.Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain).RESULTSPulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain).In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.CONCLUSIONSIn conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients. Methods We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs. Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors. Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs. Results Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients. Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed. Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed. There was no evidence of myocarditis, hepatitis, or encephalitis. Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients. Spongiosis and vascular congestion were the most frequently encountered brain lesions. No specific SARS-CoV-2 lesions were observed in any organ. IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients; RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i.e., lung, heart, spleen, liver, colon, kidney, and brain). Conclusions In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs.
ArticleNumber 495
Audience Academic
Author Peluso, Lorenzo
Taccone, Fabio Silvio
Trépant, Anne-Laure
De Mendonça, Ricardo
Remmelink, Myriam
De Clercq, Sarah
De Witte, Olivier
Verocq, Camille
Goffard, Jean-Christophe
D’Haene, Nicky
Salmon, Isabelle
Maris, Calliope
Vincent, Jean-Louis
Racu, Marie-Lucie
Rorive, Sandrine
Lebrun, Laetitia
Decaestecker, Christine
Lavis, Philomène
Author_xml – sequence: 1
  givenname: Myriam
  surname: Remmelink
  fullname: Remmelink, Myriam
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 2
  givenname: Ricardo
  surname: De Mendonça
  fullname: De Mendonça, Ricardo
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 3
  givenname: Nicky
  surname: D’Haene
  fullname: D’Haene, Nicky
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 4
  givenname: Sarah
  surname: De Clercq
  fullname: De Clercq, Sarah
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 5
  givenname: Camille
  surname: Verocq
  fullname: Verocq, Camille
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 6
  givenname: Laetitia
  surname: Lebrun
  fullname: Lebrun, Laetitia
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 7
  givenname: Philomène
  surname: Lavis
  fullname: Lavis, Philomène
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 8
  givenname: Marie-Lucie
  surname: Racu
  fullname: Racu, Marie-Lucie
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 9
  givenname: Anne-Laure
  surname: Trépant
  fullname: Trépant, Anne-Laure
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Centre Universitaire inter Régional d’expertise en Anatomie Pathologique Hospitalière (CurePath, CHIREC, CHU Tivoli, ULB)
– sequence: 10
  givenname: Calliope
  surname: Maris
  fullname: Maris, Calliope
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 11
  givenname: Sandrine
  surname: Rorive
  fullname: Rorive, Sandrine
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Centre Universitaire inter Régional d’expertise en Anatomie Pathologique Hospitalière (CurePath, CHIREC, CHU Tivoli, ULB)
– sequence: 12
  givenname: Jean-Christophe
  surname: Goffard
  fullname: Goffard, Jean-Christophe
  organization: Immunodeficiency Treatment Unit, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 13
  givenname: Olivier
  surname: De Witte
  fullname: De Witte, Olivier
  organization: Department of Neurosurgery, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 14
  givenname: Lorenzo
  surname: Peluso
  fullname: Peluso, Lorenzo
  organization: Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 15
  givenname: Jean-Louis
  surname: Vincent
  fullname: Vincent, Jean-Louis
  organization: Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 16
  givenname: Christine
  surname: Decaestecker
  fullname: Decaestecker, Christine
  organization: Laboratory of Image Synthesis and Analysis (LISA), Université Libre de Bruxelles (ULB), CPI 165/57, DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), CPI 305/1
– sequence: 17
  givenname: Fabio Silvio
  surname: Taccone
  fullname: Taccone, Fabio Silvio
  organization: Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles (ULB)
– sequence: 18
  givenname: Isabelle
  orcidid: 0000-0002-7732-2863
  surname: Salmon
  fullname: Salmon, Isabelle
  email: Isabelle.Salmon@erasme.ulb.ac.be
  organization: Department of Pathology, Erasme Hospital, Université Libre de Bruxelles (ULB), Centre Universitaire inter Régional d’expertise en Anatomie Pathologique Hospitalière (CurePath, CHIREC, CHU Tivoli, ULB), DIAPath, Center for Microscopy and Molecular Imaging, Université Libre de Bruxelles (ULB), CPI 305/1
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32787909$$D View this record in MEDLINE/PubMed
BookMark eNp9UstqHDEQHIJD_Eh-IIcwkEsu46j1mNFeAmbzWjD4YucqNFJrIzMjTaRZQ_4-Wq-d7JpgdJCQqqpV3XVaHYUYsKreAjkHkO3HDIwI3hBKGsIoyEa8qE6AtbyRgomjvfNxdZrzLSHQyZa9qo4Z7WS3IIuT6vom5AmNd97UU8xzM8Y041g7H6wP61xbzJOfsR43w-xjWutQ3_mkhzpPCbWtfaiXVz9WnxtY1JOePYY5v65eOj1kfPOwn1U3X79cL783l1ffVsuLy8a0pJsbyylK6DUh1EhOGHTUMtdLAc4BOmYpguwsR4uMUCSOUcdN57igPfDWsbNqtdO1Ud-qKflRp98qaq_uL8pvlU6zNwOqRSe1ZLQF4Tjvue0ZRw2CQMtlb4AUrU87rWnTj2hN8VFcHogevgT_U63jneo4pbxlReDDg0CKvzaYZzX6bHAYdMC4yYpyxsu4eAcF-v4J9DZuUiit2qIEkbCQe6i1LgZ8cLHUNVtRdVHqkVYKsv33-X9QZVkcvSmBcb7cHxDe7Rv96_AxEwUgdwCTYs4JnTJ-LpONW99-UEDUNn5qFz9V4qfu46dEodIn1Ef1Z0lsRyqJKpHD9K8bz7D-ALsa6b0
CitedBy_id crossref_primary_10_1007_s12024_021_00414_9
crossref_primary_10_1042_BST20241052
crossref_primary_10_1007_s00292_021_00924_x
crossref_primary_10_1007_s10238_022_00941_x
crossref_primary_10_1016_j_jacc_2022_02_003
crossref_primary_10_1093_cid_ciab760
crossref_primary_10_1164_rccm_202009_3533SO
crossref_primary_10_3390_medicina57040309
crossref_primary_10_1111_bpa_13204
crossref_primary_10_1136_bmjresp_2020_000867
crossref_primary_10_3389_fcimb_2022_794264
crossref_primary_10_1007_s12098_022_04463_y
crossref_primary_10_1016_j_prp_2021_153451
crossref_primary_10_3389_fphar_2023_1333389
crossref_primary_10_3390_microorganisms8111642
crossref_primary_10_1111_nan_12667
crossref_primary_10_1007_s00424_024_03022_y
crossref_primary_10_3390_life14020163
crossref_primary_10_1016_j_scr_2021_102436
crossref_primary_10_1097_QCO_0000000000000709
crossref_primary_10_1186_s13054_020_03302_w
crossref_primary_10_1093_brain_awab148
crossref_primary_10_1016_j_path_2023_11_006
crossref_primary_10_3390_brainsci12050536
crossref_primary_10_1128_CMR_00299_20
crossref_primary_10_1016_j_beha_2022_101377
crossref_primary_10_3748_wjg_v29_i16_2397
crossref_primary_10_1016_j_ebiom_2023_104608
crossref_primary_10_3390_diagnostics14080787
crossref_primary_10_1007_s12640_021_00389_z
crossref_primary_10_1093_infdis_jiaa745
crossref_primary_10_1038_s41541_023_00742_7
crossref_primary_10_1051_e3sconf_202129203069
crossref_primary_10_3748_wjg_v27_i35_5919
crossref_primary_10_1038_s41392_022_00891_6
crossref_primary_10_1080_09581596_2025_2557021
crossref_primary_10_3390_ijerph18041415
crossref_primary_10_1097_CCM_0000000000004895
crossref_primary_10_1111_resp_14091
crossref_primary_10_3390_jcm10215048
crossref_primary_10_1111_imr_12977
crossref_primary_10_3390_diagnostics11081357
crossref_primary_10_1016_j_cmi_2022_03_021
crossref_primary_10_1007_s00292_020_00899_1
crossref_primary_10_3390_v14010039
crossref_primary_10_1002_jmv_26570
crossref_primary_10_3390_diagnostics14030294
crossref_primary_10_3389_fnagi_2021_646908
crossref_primary_10_3748_wjg_v29_i1_200
crossref_primary_10_3390_biomedicines12040830
crossref_primary_10_4254_wjh_v13_i12_2013
crossref_primary_10_1007_s11886_021_01519_x
crossref_primary_10_1007_s11920_021_01275_3
crossref_primary_10_3390_jcm12052070
crossref_primary_10_1055_s_0042_1745871
crossref_primary_10_1097_PAP_0000000000000398
crossref_primary_10_1186_s13054_021_03631_4
crossref_primary_10_1016_j_carpath_2020_107300
crossref_primary_10_1016_j_pupt_2021_102035
crossref_primary_10_1126_sciimmunol_abo0535
crossref_primary_10_7554_eLife_60361
crossref_primary_10_1093_ajcp_aqaa264
crossref_primary_10_1172_JCI146031
crossref_primary_10_1016_j_neulet_2020_135528
crossref_primary_10_1093_jnen_nlac101
crossref_primary_10_1097_CCE_0000000000000427
crossref_primary_10_1016_j_jmoldx_2021_05_016
crossref_primary_10_1007_s00292_021_00919_8
crossref_primary_10_7759_cureus_25573
crossref_primary_10_1007_s10456_021_09805_6
crossref_primary_10_1007_s43440_023_00479_z
crossref_primary_10_1080_03007995_2022_2050110
crossref_primary_10_1186_s13054_020_03433_0
crossref_primary_10_1007_s00428_022_03319_2
crossref_primary_10_1111_ajt_16765
crossref_primary_10_3389_fmed_2021_644715
crossref_primary_10_1007_s00438_023_02014_4
crossref_primary_10_1007_s00414_023_03088_w
crossref_primary_10_1590_1806_9282_20210098
crossref_primary_10_1001_jamanetworkopen_2022_13253
crossref_primary_10_1016_j_prp_2023_154471
crossref_primary_10_7759_cureus_23538
crossref_primary_10_1097_PAS_0000000000001650
crossref_primary_10_1093_ajcp_aqad001
crossref_primary_10_3390_v13071369
crossref_primary_10_1093_jnen_nlac056
crossref_primary_10_1097_WNO_0000000000001275
crossref_primary_10_1093_ofid_ofab065
crossref_primary_10_26508_lsa_202201371
crossref_primary_10_1080_01913123_2022_2164099
crossref_primary_10_1186_s12959_021_00286_7
crossref_primary_10_3390_v14030605
crossref_primary_10_1016_j_jiph_2021_04_007
crossref_primary_10_2217_fmb_2020_0312
crossref_primary_10_3390_v15040908
crossref_primary_10_1007_s13337_022_00793_9
crossref_primary_10_1093_cid_ciab840
crossref_primary_10_3390_diagnostics13061069
crossref_primary_10_7759_cureus_35633
crossref_primary_10_3389_fimmu_2023_1129459
crossref_primary_10_1016_j_rpth_2023_100182
crossref_primary_10_1007_s11055_023_01385_w
crossref_primary_10_1159_000515104
crossref_primary_10_1186_s12987_022_00339_7
crossref_primary_10_1371_journal_pone_0311449
crossref_primary_10_3389_fcvm_2020_626975
crossref_primary_10_1038_s41392_021_00818_7
crossref_primary_10_1007_s11357_023_01058_z
crossref_primary_10_1016_S2213_2600_21_00455_0
crossref_primary_10_1186_s13054_020_03360_0
crossref_primary_10_1007_s00292_020_00900_x
crossref_primary_10_2215_CJN_16281020
crossref_primary_10_1016_j_legalmed_2021_102001
crossref_primary_10_1128_JCM_02278_20
crossref_primary_10_1186_s40478_023_01566_1
crossref_primary_10_1007_s12024_022_00518_w
crossref_primary_10_1097_MOP_0000000000001068
crossref_primary_10_1093_cvr_cvab322
crossref_primary_10_19163_1994_9480_2025_22_1_69_74
crossref_primary_10_1128_jvi_01705_21
crossref_primary_10_1111_jnc_15459
crossref_primary_10_3389_fphys_2021_613019
crossref_primary_10_1002_jmv_28384
crossref_primary_10_2147_JIR_S395331
crossref_primary_10_1097_MCP_0000000000000761
crossref_primary_10_1089_vim_2021_0126
crossref_primary_10_3748_wjg_v26_i48_7693
crossref_primary_10_1007_s00134_020_06302_0
crossref_primary_10_1007_s12015_024_10770_y
crossref_primary_10_2147_IJGM_S389300
crossref_primary_10_5500_wjt_v11_i11_480
crossref_primary_10_3390_vaccines10050774
crossref_primary_10_1161_STROKEAHA_120_032711
crossref_primary_10_4132_jptm_2023_01_30
crossref_primary_10_1002_jmv_28311
crossref_primary_10_1038_s41379_022_01069_9
crossref_primary_10_1097_QCO_0000000000000731
crossref_primary_10_1097_ID9_0000000000000166
crossref_primary_10_1186_s13054_021_03467_y
crossref_primary_10_1007_s12024_022_00494_1
crossref_primary_10_1038_s41586_022_05542_y
crossref_primary_10_1038_s41581_021_00452_0
crossref_primary_10_1016_j_cell_2021_12_040
crossref_primary_10_1111_nan_12752
crossref_primary_10_3390_pathogens10040412
crossref_primary_10_1007_s00415_021_10581_y
crossref_primary_10_3390_cells10081900
crossref_primary_10_1097_MNH_0000000000000708
crossref_primary_10_1007_s00292_021_00920_1
crossref_primary_10_1016_j_prp_2024_155373
crossref_primary_10_1016_j_iccn_2020_103011
crossref_primary_10_3389_fimmu_2021_665773
crossref_primary_10_3389_fimmu_2022_941663
crossref_primary_10_1371_journal_pone_0254872
crossref_primary_10_3390_biomedicines11051474
crossref_primary_10_1186_s13054_021_03607_4
crossref_primary_10_1016_j_ebiom_2020_103104
crossref_primary_10_3390_v16010060
crossref_primary_10_1007_s00705_023_05711_y
crossref_primary_10_1093_cid_ciab812
crossref_primary_10_1111_hdi_12935
crossref_primary_10_1002_cyto_a_24280
crossref_primary_10_1097_TP_0000000000003744
crossref_primary_10_3389_fphar_2021_614586
crossref_primary_10_3390_biom12050629
crossref_primary_10_1002_jmv_26943
crossref_primary_10_1016_S1773_035X_20_30391_9
crossref_primary_10_1136_bmjopen_2021_049083
crossref_primary_10_3389_fcell_2020_605972
crossref_primary_10_1080_14737159_2022_2085508
crossref_primary_10_3390_ijms22084081
crossref_primary_10_1080_10408363_2021_1944047
crossref_primary_10_1111_1751_7915_13828
crossref_primary_10_1093_qjmed_hcac272
crossref_primary_10_3390_medsci10040058
crossref_primary_10_1016_j_jri_2022_103763
Cites_doi 10.1378/chest.08-1741
10.1097/SHK.0b013e31824c3238
10.1093/ajcp/aqaa062
10.1038/modpathol.3800247
10.1111/his.14134
10.1038/s41586-020-2196-x
10.1038/s41379-020-0603-3
10.1001/jamacardio.2020.0950
10.3390/cancers11060773
10.1007/s00134-020-06057-8
10.1016/S2213-2600(20)30076-X
10.1016/S0046-8177(03)00367-8
10.1111/jth.14869
10.1056/NEJMoa2002032
10.1016/S0140-6736(20)30937-5
10.1016/j.cell.2020.02.052
10.1016/S0140-6736(03)13413-7
10.1016/j.pathophys.2019.04.001
10.1136/bmj.m1091
10.1186/s13054-020-02880-z
10.1186/cc11454
10.1001/jama.2020.1585
10.7326/M20-2003
10.1177/1076029619887437
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13054-020-03218-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE


MEDLINE - Academic
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1364-8535
1466-609X
1366-609X
EndPage 10
ExternalDocumentID oai_doaj_org_article_978a832615f44b4db34ea1501648bc10
PMC7422463
A633068500
32787909
10_1186_s13054_020_03218_5
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: European Regional Development Fund
  funderid: http://dx.doi.org/10.13039/501100008530
– fundername: Fondation ULB
– fundername: Fonds Y. Boel
– fundername: Walloon Region of Belgium
  grantid: 411132-957270
– fundername: Fonds Erasme
– fundername: ;
– fundername: ;
  grantid: 411132-957270
GroupedDBID ---
0R~
29F
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
OK1
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
ROL
RPM
RSV
SJN
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
YOC
.6V
AAYXX
AFFHD
CITATION
-5E
-5G
-BR
3V.
ACRMQ
ADINQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c607t-d42e81ba002c8403172d3fb851ff1ef3d2e187d4ede302e0f32f4c7f452b146f3
IEDL.DBID RSV
ISICitedReferencesCount 223
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000563369000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1364-8535
1466-609X
IngestDate Fri Oct 03 12:51:07 EDT 2025
Tue Nov 04 02:00:56 EST 2025
Thu Sep 04 15:41:59 EDT 2025
Tue Oct 14 12:40:53 EDT 2025
Sat Nov 29 13:38:54 EST 2025
Sat Nov 29 09:52:58 EST 2025
Thu Jan 02 22:58:55 EST 2025
Sat Nov 29 06:02:06 EST 2025
Tue Nov 18 21:33:46 EST 2025
Sat Sep 06 07:25:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords COVID-19
Immunohistochemistry
SARS-CoV-2
Autopsy
RT-PCR
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-d42e81ba002c8403172d3fb851ff1ef3d2e187d4ede302e0f32f4c7f452b146f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7732-2863
OpenAccessLink https://link.springer.com/10.1186/s13054-020-03218-5
PMID 32787909
PQID 2435081981
PQPubID 44362
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_978a832615f44b4db34ea1501648bc10
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7422463
proquest_miscellaneous_2434054471
proquest_journals_2435081981
gale_infotracmisc_A633068500
gale_infotracacademiconefile_A633068500
pubmed_primary_32787909
crossref_citationtrail_10_1186_s13054_020_03218_5
crossref_primary_10_1186_s13054_020_03218_5
springer_journals_10_1186_s13054_020_03218_5
PublicationCentury 2000
PublicationDate 2020-08-12
PublicationDateYYYYMMDD 2020-08-12
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-12
  day: 12
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Critical care (London, England)
PublicationTitleAbbrev Crit Care
PublicationTitleAlternate Crit Care
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References C Santos (3218_CR20) 2019; 26
R Wölfel (3218_CR27) 2020; 581
LM Barton (3218_CR7) 2020; 153
L Gattinoni (3218_CR18) 2020; 24
3218_CR24
3218_CR25
WJ Guan (3218_CR1) 2020; 382
L Smeding (3218_CR26) 2012; 37
Z Varga (3218_CR4) 2020; 395
JC Chang (3218_CR23) 2019; 25
N D'Haene (3218_CR11) 2019; 11
3218_CR3
3218_CR5
3218_CR21
JM Nicholls (3218_CR16) 2003; 361
TJ Franks (3218_CR15) 2003; 34
3218_CR19
VM Corman (3218_CR12) 2020; 25
VM Ranieri (3218_CR8) 2012; 307
JA Kellum (3218_CR9) 2013; 17
D Hwang (3218_CR17) 2005; 18
M Hoffmann (3218_CR2) 2020; 181
Q de Hemptinne (3218_CR13) 2009; 135
3218_CR14
Z Xu (3218_CR6) 2020; 8
JF Llitjos (3218_CR22) 2020; 18
3218_CR10
References_xml – volume: 25
  start-page: 2000045
  year: 2020
  ident: 3218_CR12
  publication-title: Euro Surveill
– volume: 135
  start-page: 944
  year: 2009
  ident: 3218_CR13
  publication-title: Chest.
  doi: 10.1378/chest.08-1741
– volume: 37
  start-page: 449
  year: 2012
  ident: 3218_CR26
  publication-title: Shock.
  doi: 10.1097/SHK.0b013e31824c3238
– volume: 153
  start-page: 725
  year: 2020
  ident: 3218_CR7
  publication-title: USA Am J Clin Pathol
  doi: 10.1093/ajcp/aqaa062
– volume: 18
  start-page: 1
  year: 2005
  ident: 3218_CR17
  publication-title: Mod Pathol
  doi: 10.1038/modpathol.3800247
– ident: 3218_CR14
  doi: 10.1111/his.14134
– volume: 307
  start-page: 2526
  year: 2012
  ident: 3218_CR8
  publication-title: JAMA.
– ident: 3218_CR10
– volume: 581
  start-page: 465
  year: 2020
  ident: 3218_CR27
  publication-title: Nature.
  doi: 10.1038/s41586-020-2196-x
– ident: 3218_CR24
  doi: 10.1038/s41379-020-0603-3
– ident: 3218_CR25
  doi: 10.1001/jamacardio.2020.0950
– volume: 11
  start-page: 773
  year: 2019
  ident: 3218_CR11
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers11060773
– ident: 3218_CR19
  doi: 10.1007/s00134-020-06057-8
– volume: 8
  start-page: 420
  year: 2020
  ident: 3218_CR6
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 34
  start-page: 743
  year: 2003
  ident: 3218_CR15
  publication-title: Hum Pathol
  doi: 10.1016/S0046-8177(03)00367-8
– volume: 18
  start-page: 1743
  year: 2020
  ident: 3218_CR22
  publication-title: J Thromb Haemost
  doi: 10.1111/jth.14869
– volume: 382
  start-page: 1708
  year: 2020
  ident: 3218_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2002032
– volume: 395
  start-page: 1417
  year: 2020
  ident: 3218_CR4
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(20)30937-5
– volume: 181
  start-page: 1
  year: 2020
  ident: 3218_CR2
  publication-title: Cell.
  doi: 10.1016/j.cell.2020.02.052
– volume: 361
  start-page: 1773
  year: 2003
  ident: 3218_CR16
  publication-title: Lancet.
  doi: 10.1016/S0140-6736(03)13413-7
– volume: 26
  start-page: 213
  year: 2019
  ident: 3218_CR20
  publication-title: Pathophysiology.
  doi: 10.1016/j.pathophys.2019.04.001
– ident: 3218_CR5
  doi: 10.1136/bmj.m1091
– volume: 24
  start-page: 154
  year: 2020
  ident: 3218_CR18
  publication-title: Crit Care
  doi: 10.1186/s13054-020-02880-z
– volume: 17
  start-page: 204
  year: 2013
  ident: 3218_CR9
  publication-title: Crit Care
  doi: 10.1186/cc11454
– ident: 3218_CR21
  doi: 10.1001/jama.2020.1585
– ident: 3218_CR3
  doi: 10.7326/M20-2003
– volume: 25
  start-page: 107602961988743
  year: 2019
  ident: 3218_CR23
  publication-title: Clin Appl Thromb Hemost
  doi: 10.1177/1076029619887437
SSID ssj0017863
Score 2.6686444
Snippet Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different...
Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in...
Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different...
Abstract Background Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 495
SubjectTerms Aged
Autopsy
Betacoronavirus - isolation & purification
Brain - virology
Brain damage
Cardiovascular disease
Colon - virology
Coronavirus Infections - therapy
Coronavirus Infections - virology
Coronaviruses
COVID-19
Critical care
Critical Care Medicine
Emergency Medicine
Fatalities
Female
Health aspects
Heart - virology
Hemorrhage
Humans
Immunohistochemistry
Intensive
Kidney - virology
Kidneys
Laboratories
Liver - virology
Lung - virology
Lungs
Male
Medical research
Medicine
Medicine & Public Health
Methenamine
Middle Aged
Morphology
Mortality
Pandemics
Patients
Pneumonia
Pneumonia, Viral - therapy
Pneumonia, Viral - virology
Proteins
Pulmonary arteries
Respiratory diseases
Reverse Transcriptase Polymerase Chain Reaction
RT-PCR
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Spleen - virology
Viral infections
Viruses
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hqkJcEOUZWpCRkDiAhV9J7GNbqECCwqGterMSx4aVqmzVbPv7O3acpSkCLlzXjtae5zeahwFeuyqoRpSaNrH3Q3muaNM4SUOpjSiD9CqlC06-1IeH-vTUfL_x1FesCRvHA4-EixNgG5Q6dLxBqVZ1rVS-QRSDMF-3bmyuYrWZgqmcP6h1JacWGV29H9BSl4rGUIlJdGq0nLmhNK3_d5t8wyndLpi8lTVNzujgAdzPKJLsjqffgju-fwh3v-Y8-SM4Ou5jC2UsAyLnywFj21RTS1KGuv8xkC5m2FeepHrC9LITidW-ZwT_EblOFj3Z_3by-QPlhuTRq8NjOD74eLT_ieb3E6irWL2inRIeUWmDRs9hHIdIQXQytIixQuA-yE54rutO-c5LJjwLUgTl6qBK0aIBDfIJbPTL3j8Dwp3hIvjATFMqL7QOXjvhDFOOKc66AvhETuvycPH4xsWZTUGGruzIAosssIkFtizg7fqb83G0xl9370UurXfGsdjpB6SRzcJi_yUsBbyJPLZRefF4rsk9CHjJOAbL7lYSQyhdMty5M9uJSufmy5OU2Kz0gxUIPSPC0ryAV-vl-GUsZOv98jLtQYisEBIU8HQUqvWVpEDraZgpoJ6J2-zO85V-8TONBK9VHAwoC3g3CeavY_2Zps__B0234Z5IiqUpFzuwsbq49C9g012tFsPFy6SW10KlNfY
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9UwDI9gIMSF74_CQEFC4gDR8tmmJzQGE0gwOGzTu0V9aQJPmvoe6xt_P3Ze2tEhduHauFJcOz_btWMT8tKXUTfSWNbg3Q8dhGZN4xWLxtbSRBV0Shccf64ODuxsVn_LP9z6XFY5YGIC6nbp8R_5jgS7jubLirernwynRmF2NY_QuEqu4dhs1PNqNgZcorJpkppQpWZglsxwacaWOz1gt9EMgyeuwMwxMzFMqX__3yj9h5m6WEJ5IY-azNP-7f9l7A65lR1TurvRpLvkSujukRtfcur9Pjk86vBWJlYW0dWyh3A5lenSlPTuvve0xaT9OtBUopiGRVEsID6hsGVQJLro6N7X40_vmahp7ubaPyBH-x8O9z6yPJKB-ZJXa9ZqGcDRbQBHPYSG4HzIVsU5uG0xihBVKwPIodWhDYrLwKOSUfsqaiPngMlRPSRb3bILjwkVvhYyhsjrxuggrY3Beulrrj3XgrcFEYM8nM_9ynFsxolLcYst3UaGDmTokgydKcjr8Z3VplvHpdTvUMwjJXbaTg_gG7l8cB1E2Q2gHjh-Ueu5budKhwa8aAgz7dwLXpBXqCQO8QC255t8rQGYxM5abrdUEJVZw4Fye0IJ59hPlwf9cBlHeneuHAV5MS7jm1gb14XlWaIBr1uDl1GQRxutHFlSEgC55nVBqom-TniernSLH6nLeKWx16AqyJtBs8-39e9v-uRyLp6SmzKdOcuE3CZb69Oz8Ixc97_Wi_70eTq9vwE-3Ebr
  priority: 102
  providerName: ProQuest
Title Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients
URI https://link.springer.com/article/10.1186/s13054-020-03218-5
https://www.ncbi.nlm.nih.gov/pubmed/32787909
https://www.proquest.com/docview/2435081981
https://www.proquest.com/docview/2434054471
https://pubmed.ncbi.nlm.nih.gov/PMC7422463
https://doaj.org/article/978a832615f44b4db34ea1501648bc10
Volume 24
WOSCitedRecordID wos000563369000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: RBZ
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 20231231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: DOA
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: 7X7
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: BENPR
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: PIMPY
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLink
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: RSV
  dateStart: 19970401
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB7RFiFeuI9AWRkJiQew6iuJ89iWVlSiy6q0q-XJShwbVqqyVbPl9zP2JgsphwQvkTYeS_ZkZvzNzmGAVzbzqhSppmWo_VCOK1qWVlKf6kKkXjoVwwXTD_l4rGezYtIVhbV9tnsfkoyWOqq1znZatLaposHdYRIPJppuwBYedzpc2HDyabqOHeQ6k315zG_nDY6g2Kn_V3v804F0PVnyWsQ0HkSHd_9vC_fgTgc8ye5KUu7DDdc8gFvHXWj9IZyeNaHqMmQOkYtFi-5wTMMlMajdfGlJHYLyS0diCmK8DIqEBOFzgotAQSHzhux_nB69o7wgXbfW9hGcHR6c7r-n3ZUL1GYsX9JaCYdAtkQ7adH1Q3AhaukrhGXec-dlLRzXea1c7SQTjnkpvLK5V6mo0OZ6-Rg2m0XjngLhtuDCO8-KMlVOaO2dtsIWTFmmOKsT4P1XMLbrRx6uxTg30S_RmVmxyyC7TGSXSRN4s55zserG8VfqvfBx15Shk3Z8gTwynWIa9KJLtGoI7LxSlaorqVyJKBndSF1ZzhJ4HUTDBH3H5dmyK1vATYbOWWY3k-h16ZQh5faAEvXUDod74TKdnWiNQLQaQJnmCbxcD4eZIfetcYurSIOoWiGKSODJShbXW5ICDW7BigTygZQO9jwcaeZfYxfxXIVegjKBt72s_ljWn3n67N_In8NtEcVdUy62YXN5eeVewE37bTlvL0ewkc_y-NQj2No7GE9ORvFPEfw1OTqefB5Fzf4Om11BJw
linkProvider Springer Nature
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70eggJFAHIrV-JHEOSBUWqquul04bKu9maxjw0oluzRbEH-K38jYm2xJEb31wDV2oowz830z8XgG4IVJnSx4omjhz35IyyQtCiOoS1TOEyesDNsFh_1sMFCjUf5xBX61Z2F8WmWLiQGoy6nx_8g3OPK6py_F3s6-Ud81yu-uti00FmqxZ3_-wJCtftPbxu_7kvOd98OtXdp0FaAmjbM5LSW36KsVCAUGoxvkT14KN0bPwzlmnSi5ZSorpS2tiLmNneBOmszJhI8RVpzA516Cy4jjmQ_2stEywGOZCp3bmEglRRpM2kM6Kt2okSsSSX2wFgukVZp0iDD0C_ibFf6gxbMpm2f2bQMd7tz83xbyFtxoHG-yubCU27Biqztwdb9JLbgLw4PKnzr1mVNkNq3n9GtIQyZhU7_6XJPSJyXMLQkpmKEZFvEJ0kcElwgNhUwqsvXhsLdNWU6aarX1PTi4EJnuw2o1rexDIMzkjDvr4rxIpOVKOasMN3ksTSxZXEbA2u-vTVOP3bcFOdIhLlOpXuiMRp3RQWd0EsH68p7ZohrJubPfebVazvSVxMMFXCPdAJPOM1UgqqNj66Qcy3IspC0wSsAwWo0NiyN45ZVSe7zD1zNFc2wDhfSVw_RmKjDqVEmMM9c6MxGnTHe41Ufd4GStT5UxgufLYX-nz_2r7PQkzMGoQqIXFcGDhRUsRRIcCSeP8wiyjn10ZO6OVJMvoYp6Jn0tRRHB69aSTl_r32v66HwpnsG13eF-X_d7g73HcJ0He1eU8TVYnR-f2CdwxXyfT-rjpwE5CHy6aAv7DQ5So94
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BQRUX3oVAASMhcYCofiVxjqVlRUVZKtGuerMSx4aVquyqSfn9jJ0HTXlIiGsyluzxePyNZuYzwCuTOlnwRMWF7_2Qlsm4KIyIXaJynjhhZUgXLA6z-VydnuZHl7r4Q7X7kJLseho8S1Pd7qwr1x1xle406HkTGfvQhwq8pOLkOtyQvpDex-tfFmMeIVOpGFplfjtuch0F1v5fffOly-lq4eSV7Gm4lGZ3_n85d-F2D0jJbmdB9-Care_D5qc-5f4Ajk9q343pK4rIetVgmBzKc0lIdtdfG1L5ZH1rSShNDI9EEV84fEZwQmhAZFmTvc-Lg_2Y5aRncW0ewsns_fHeh7h_iiE2Kc3auJLcIsAt0H8aDAkRdPBKuBLhmnPMOlFxy1RWSVtZQbmlTnAnTeZkwkv0xU5swUa9qu1jIMzkjDvraF4k0nKlnFWGm5xKQ3ELqwjYsCPa9Dzl_rmMMx3iFZXqTl0a1aWDunQSwZtxzLpj6fir9Du_0aOkZ9gOH1BHuj-wGqPrAr0dAj4nZSmrUkhbIHrG8FKVhtEIXnsz0d4P4PRM0bcz4CI9o5beTQVGYyqhKLk9kcTza6a_B0PTvf9oNEcU68GaYhG8HH_7kb4mrrariyCDaFsiuojgUWeX45IER0ec0zyCbGKxkzVP_9TLb4FdPJOeY1BE8Haw25_T-rNOn_yb-AvYPNqf6cOD-cencIsHy1cx49uw0Z5f2Gdw03xvl83583CcfwB3Akbf
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unspecific+post-mortem+findings+despite+multiorgan+viral+spread+in+COVID-19+patients&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Remmelink%2C+Myriam&rft.au=De+Mendon%C3%A7a%2C+Ricardo&rft.au=D%27Haene%2C+Nicky&rft.au=De+Clercq%2C+Sarah&rft.date=2020-08-12&rft.issn=1466-609X&rft.eissn=1466-609X&rft.volume=24&rft.issue=1&rft.spage=495&rft_id=info:doi/10.1186%2Fs13054-020-03218-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon